4-WF

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name4-WF
Drug Alias NameApoA-I mimetics (Esperion/Cleveland Clinic)HDL-based therapeutics (Esperion/Cleveland Clinic)synthetic HDL therapy (Esperion/Cleveland Clinic)4-WF
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionApolipoprotein A-I modulators
TargetsApolipoprotein A-I
Therapy Area/IndicationsAtherosclerosisCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Cleveland Clinic Foundation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Cleveland Clinic FoundationEsperion Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAtherosclerosisCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A